Clinical literature consistently demonstrates that patients taking anticoagulant medications must disclose this information to dental professionals prior to invasive procedures so that bleeding risks and local hemostatic measures can be properly managed.
All relevant retrieved studies focus on the management, risk stratification, and safety protocols for patients on anticoagulants or antithrombotic therapies undergoing dental and oral surgical procedures. The evidence universally points to the necessity of disclosing and evaluating these medications beforehand to prevent hemorrhagic complications, supporting the claim.